Table 1. CL episodes by year and country.
| Year(s) | Nation | National Income Group | Disease | Disease Group | Total Products | Outcome |
| 2001 (2007) | Brazil | UMIC | HIV/AIDS | HIV/AIDS | 2 | CL/discount |
| 2001 | Brazil | UMIC | HIV/AIDS | HIV/AIDS | 1 | Discount |
| 2001 | Canada | HIC | Anthrax | CD | 1 | Discount |
| 2001–2003 | South Africa | UMIC | HIV/AIDS | HIV/AIDS | 8 | VL/discount/none |
| 2001 | United States | HIC | Anthrax | CD | 1 | Discount |
| 2002 | Egypt | LIC | Erectile dysfunction | NCD | 1 | CL |
| 2003–2004 | Malaysia | UMIC | HIV/AIDS | HIV/AIDS | 3 | CL |
| 2003, 2007 | Brazil | UMIC | HIV/AIDS | HIV/AIDS | 1 | Discount |
| 2003 | Zimbabwe | LIC | HIV/AIDS | HIV/AIDS | All | CL |
| 2004 | Mozambique | LDC | HIV/AIDS | HIV/AIDS | 3 | CL |
| 2004 | Zambia | LDC | HIV/AIDS | HIV/AIDS | 3 | CL |
| 2005–2006 | Argentina | UMIC | Pandemic flu | CD | 1 | VL |
| 2005–2007 | Brazil | UMIC | HIV/AIDS | HIV/AIDS | 1 | Discount |
| 2005–2009 | Brazil | UMIC | HIV/AIDS | HIV/AIDS | 1 | Discount |
| 2005 | Ghana | LIC | HIV/AIDS | HIV/AIDS | All | CL |
| 2005 | Indonesia | LIC | HIV/AIDS | HIV/AIDS | 2 | CL |
| 2005 | Taiwan | HIC | Pandemic flu | CD | 1 | VL |
| 2006–2007 | India | LIC | Cancer | NCD | 1 | None |
| 2006 (2010) | Thailand | UMIC | HIV/AIDS | HIV/AIDS | 1 | CL |
| 2007 | Rwanda | LDC | HIV/AIDS | HIV/AIDS | 1 | CL |
| 2007 (2010) | Thailand | UMIC | HIV/AIDS, CVD | HIV/AIDS, NCD | 2 | CL |
| 2007–2008 | Thailand | UMIC | Cancer | NCD | 1 | Discount |
| 2007–2008 | Thailand | UMIC | Cancer | NCD | 3 | CL |
| 2010 | Ecuador | UMIC | HIV/AIDS | HIV/AIDS | 1 | CL |
Totals: 24 Episodes, 17 Nations, 40 Unique Drug-Nation Combinations +2 Categorical CLs. Years in parentheses indicate CL renewals.
CVD, cardiovascular disease.